In the highly competitive and highly regulated pharmaceutical industry, the key to success is multifaceted. Pharmaceutical companies need true strategic partners that understand the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, and protecting existing product lines.
Goodwin is that partner. We have made servicing the needs of the pharmaceutical industry a strategic priority for more than two decades, and we have one of the largest, most active and most experienced pharmaceutical practices in the United States.
Our interdisciplinary pharmaceutical industry practice is deeply experienced in corporate governance, financing and M&A transactions, collaborations and licensing, and regulatory matters, as well as Hatch-Waxman and biosimilars patent litigation, products litigation and counseling, privacy and cybersecurity, employment and tax. Our depth of experience across the full spectrum of services needed by pharmaceutical clients is just one reason that Goodwin is one of just ten firms consistently recognized by LMG Life Sciences as a “Life Cycle Firm.”
